Showing results (81-90 of 497) with videos related to

Sort By:
Pageof 50
Blood|May 2, 2024
CAR T cells vs bispecific antibody as third- or later-line large B-cell lymphoma therapy: a meta-analysisJinchul Kim, Jinhyun Cho, Moon Hee Lee, et al.
Leukemia & Lymphoma|July 7, 2018
Serum IL18 is associated with hemophagocytosis and poor survival in extranodal natural killer/T-cell lymphomaSung Won Lim, Kyung Ju Ryu, Hansang Lee, et al.
Cancer Research and Treatment|March 13, 2015
Cross-sectional Study of Patients with Diffuse Large B-Cell Lymphoma: Assessing the Effect of Host Status, Tumor Burden, and Inflammatory Activity on Venous ThromboembolismSung Hee Lim, Sook-Young Woo, Seonwoo Kim, et al.
The Korean Journal of Internal Medicine|April 3, 2019
Real world data on follicular lymphoma patients treated by rituximab-containing immunochemotherapy and rituximab maintenanceHee Kyung Kim, Wonseok Kang, Dong Hyun Sinn, et al.
Journal of Pathology and Translational Medicine|January 17, 2024
Tumor-infiltrating T lymphocytes evaluated using digital image analysis predict the prognosis of patients with diffuse large B-cell lymphomaYunjoo Cho, Jiyeon Lee, Bogyeong Han, et al.
The Lancet. Oncology|November 3, 2009
Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009Yok-Lam Kwong, Benjamin O Anderson, Ranjana Advani, et al.
FEBS Letters|January 30, 2007
Egr-1, a new downstream molecule of Epstein-Barr virus latent membrane protein 1Joo Hyun Kim, Won Seog Kim, Jung Hun Kang, et al.
Cancer Research and Treatment|February 5, 2015
Clinical Significance of Non-neutropenic Fever in the Management of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Comparison with Febrile Neutropenia and Risk Factor AnalysisSilvia Park, Cheol-In Kang, Doo Ryeon Chung, et al.
Cancer Research and Treatment|January 16, 2024
Feasibility of Circulating Tumor DNA Analysis in Patients with Follicular LymphomaSang Eun Yoon, Seung-Ho Shin, Dae Keun Nam, et al.
Cancer Research and Treatment|July 3, 2025
Detection of HIV RNA after CAR-T Cell Therapy in A Relapsed/refractory Diffuse Large B-cell Lymphoma Patient: Possibility of False Positivity and Clinical ImplicationsSang Eun Yoon, Kyungmin Huh, Tae Yeul Kim, et al.
Pageof 50